| Christopher Fitzsimmons, | |
|
1530 N 7th St, Suite 200, Terre Haute, IN 47807-1057 | |
| (812) 238-7631 | |
| Not Available |
| Full Name | Christopher Fitzsimmons |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 1530 N 7th St, Terre Haute, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083020580 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 11017535A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Visiting Nurse Association Of The Wabash Valley In | Terre haute, IN | Home health agency |
| Amedisys Home Health | Bloomington, IN | Home health agency |
| Union Hospital Clinton | Clinton, IN | Hospital |
| Union Hospital Inc | Terre haute, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Union Associated Physicians Clinic Llc | 3375687437 | 159 |
| Valley Professionals Community Health Center Inc | 7618067265 | 60 |
News Archive
Women with larger cup sizes seem to be more susceptible, but childless women also seem to be more prone, and wearing a sports bra doesn't always help, finds the study, which publishes as London gears up for its annual international marathon tomorrow (Sunday April 21).
Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £6 million through a rights issue to existing investors in an oversubscribed round. This is the third successful funding round for Microvisk, which has secured £10.5m in the past 12 months - the largest amount raised by a UK life science company**.
Cells from healthy individuals with major depressive disorder were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of Walter Reed Army Institute of Research and University of California San Francisco scientists, in collaboration with others.
Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company's Access Family of Immunoassay Systems.
› Verified 1 days ago
| Entity Name | Valley Professionals Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104006253 PECOS PAC ID: 7618067265 Enrollment ID: O20071219000487 |
News Archive
Women with larger cup sizes seem to be more susceptible, but childless women also seem to be more prone, and wearing a sports bra doesn't always help, finds the study, which publishes as London gears up for its annual international marathon tomorrow (Sunday April 21).
Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £6 million through a rights issue to existing investors in an oversubscribed round. This is the third successful funding round for Microvisk, which has secured £10.5m in the past 12 months - the largest amount raised by a UK life science company**.
Cells from healthy individuals with major depressive disorder were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of Walter Reed Army Institute of Research and University of California San Francisco scientists, in collaboration with others.
Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company's Access Family of Immunoassay Systems.
› Verified 1 days ago
| Entity Name | Union Associated Physicians Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891028379 PECOS PAC ID: 3375687437 Enrollment ID: O20100213000002 |
News Archive
Women with larger cup sizes seem to be more susceptible, but childless women also seem to be more prone, and wearing a sports bra doesn't always help, finds the study, which publishes as London gears up for its annual international marathon tomorrow (Sunday April 21).
Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £6 million through a rights issue to existing investors in an oversubscribed round. This is the third successful funding round for Microvisk, which has secured £10.5m in the past 12 months - the largest amount raised by a UK life science company**.
Cells from healthy individuals with major depressive disorder were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of Walter Reed Army Institute of Research and University of California San Francisco scientists, in collaboration with others.
Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company's Access Family of Immunoassay Systems.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Fitzsimmons, 1530 N 7th St, Suite 200, Terre Haute, IN 47807-1057 Ph: (812) 238-7631 | Christopher Fitzsimmons, 1530 N 7th St, Suite 200, Terre Haute, IN 47807-1057 Ph: (812) 238-7631 |
News Archive
Women with larger cup sizes seem to be more susceptible, but childless women also seem to be more prone, and wearing a sports bra doesn't always help, finds the study, which publishes as London gears up for its annual international marathon tomorrow (Sunday April 21).
Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £6 million through a rights issue to existing investors in an oversubscribed round. This is the third successful funding round for Microvisk, which has secured £10.5m in the past 12 months - the largest amount raised by a UK life science company**.
Cells from healthy individuals with major depressive disorder were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of Walter Reed Army Institute of Research and University of California San Francisco scientists, in collaboration with others.
Beckman Coulter Diagnostics is pleased to announce obtaining CE Mark and the release of its new Access TSH (3rd IS) assay for use with the company's Access Family of Immunoassay Systems.
› Verified 1 days ago
Anna M Zimmerman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1739 N 4th St, Terre Haute, IN 47804 Phone: 812-242-3600 Fax: 812-242-3620 | |
Dr. Grace Lee Walker, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 476 Buckeye St, Terre Haute, IN 47804 Phone: 812-232-2683 Fax: 812-877-4620 | |
Marcia L Favali, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 221 S 6th St, Terre Haute, IN 47807 Phone: 812-242-3120 Fax: 812-242-3846 | |
Nancy Lynn Breitweiser, M. D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1513 N 6th 1/2 St, Terre Haute, IN 47807 Phone: 812-238-7631 Fax: 812-238-7003 | |
John Len Wheat, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 88 Wabash Ct, Terre Haute, IN 47807 Phone: 812-231-8484 | |
Melissa R Hunt, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1530 N 7th St, Terre Haute, IN 47807 Phone: 812-238-7878 |